Navigation Links
Pharmaceutical Commercial Leaders Seek Global Benchmarks for More Informed Decision-Making
Date:5/21/2012

CHAPEL HILL, N.C., May 21, 2012 /PRNewswire/ -- Savvy vice presidents and directors across all pharmaceutical commercial functions are searching now for best-in-class organizational structures, critical activities, proven processes, and investment benchmarks that ensure sustained growth across global markets.

"In today's increasingly competitive health care environment, global leaders and managers need to have analysis from across the worldwide marketplace," says Best Practices CEO, Chris Bogan. "Information from one country or region is not enough."

To support pharmaceutical leaders tasked with global oversight of structuring, resourcing, and strategic planning, Best Practices, LLC launches Global Management Navigator within the Wizards & Analytics Search (http://www3.best-in-class.com/rw16.htm).

"The Global Management Navigator puts benchmarking research, insights and analysis from a worldwide perspective into leaders' hands and supports evidence-based and informed decision-making," Bogan explains. The new Wizard searches the Best Practice Database for global benchmarks in a specified function, group, process or role.

For example, one often-searched health care area is "medical science liaisons," a highly knowledgeable group who provide critical medical information to the practicing community on behalf of the companies that manufacture new medicines and/or devices. To demonstrate the power of the new search Wizards in the Best Practice Database Global Management Navigator using the popular search term "medical science liaisons," simply:

How to Use the Global Management Navigator:

  • Visit the Global Management Navigator at http://www3.best-in-class.com/rw16.htm.   
  • In the fifth text box, insert the evolving role of "medical science liaisons" in quotations.
  • Click the "Search Now" button to the right of the text box.
  • Review the list of relevant documents in the Best Practice Database.
  • Click on the document titles of most interest, including the first hit "Medical Science Liaison Services Excellence: Managing Internal Activities and Providing Oversight." (http://www3.best-in-class.com/rr1155.htm)

Best Practice Database documents include benchmarks and insights gathered from quantitative and qualitative primary research with executives at pharmaceutical companies. Subscribers to the Best Practice Database have access to these primary research results to make informed decisions in their functional areas. Within the documents, charts, graphs, and process maps enable executives to assess resource levels, responsibility scope, and performance metrics of their function.

For more information on the Global Management Navigator or how to determine if your group is among the low performers or the best-in-class performers, contact us at 919.403.0251 or at bestpractices@best-in-class.com.  

BEST PRACTICES, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide.

Best Practices, LLC's clients include the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our reports, database, and advisory services to support executives in commercial and R&D operations.


'/>"/>
SOURCE Best Practices, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
7. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
8. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
10. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
11. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... Research and Markets has announced the addition of ... to their offering. ... latest research Hemophilia Drugs Price Analysis and Strategies - 2016, provides drug ... answers the following questions: What are the ... positioned in the Global Hemophilia market? What are the ...
(Date:2/24/2017)... -- Physician General Dr. Rachel Levine and ... Smith commended South Central EMS today for their ... a life-saving overdose reversal drug. The recognition event also ... overdose survivor who was saved due to the administration ... part of fighting the opioid epidemic is making sure ...
(Date:2/24/2017)... HILL, N.C. , Feb. 24, 2017 /PRNewswire/ ... are exploring ways to increase their self-service capabilities ... Health Care Providers (HCPs). New research ... many pharma organizations have developed self-service website portals ... electronically.  This is just one of many findings ...
Breaking Medicine Technology:
(Date:2/24/2017)... Prior Lake MN (PRWEB) , ... February 24, ... ... the launch of its newly designed TaskMate Go. Core benefits and advantages built ... grain finish and a stylish, functional look and feel. Ability to gain the ...
(Date:2/24/2017)... ... February 24, 2017 , ... An in-depth computational analysis ... University of Pittsburgh points to eight genes that may explain why susceptibility to one ... the results of a study published today in the journal npj Schizophrenia. , ...
(Date:2/24/2017)... ... February 24, 2017 , ... With ... is so critically important that we all are aware of our options and ... is proud to announce the launch of its newest edition of "Vision and ...
(Date:2/24/2017)... ... February 24, 2017 , ... The California State University Institute ... faculty engaged in or interested in palliative care education and research. The Symposium, ... in North County San Diego on Sept. 28 and 29, 2017, on the campus ...
(Date:2/24/2017)... ... ... The Radiology Business Management Association will select the 2017 ... Building Better Radiology Marketing Programs conference, held this year from March 5 to ... are given out in five categories. They are:, ,     Patient Marketing, ...
Breaking Medicine News(10 mins):